A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Gespeichert in:
| Veröffentlicht in: | Clinical cancer research 2021-11, Vol.28 (3), p.452-460 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 460 |
|---|---|
| container_issue | 3 |
| container_start_page | 452 |
| container_title | Clinical cancer research |
| container_volume | 28 |
| creator | Lassman, Andrew B. Wen, Patrick Y. van den Bent, Martin Plotkin, Scott R. Walenkamp, Annemiek M. E. Green, Adam L. Li, Kai Walker, Christopher J. Chang, Hua Tamir, Sharon Henegar, Leah Shen, Yao Alvarez, Mariano J. Califano, Andrea Landesman, Yosef Kauffman, Michael G. Shacham, Sharon Mau-Soerensen, Morten |
| description | |
| doi_str_mv | 10.1158/1078-0432.CCR-21-2225 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8810630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8810630</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_88106303</originalsourceid><addsrcrecordid>eNqljNFKwzAYRoMoblMfQfhfIDNJmzVXgpTp7pR1eBuyNrGRNBlJKvbtLaIXXnv1fXAOB6FbStaUcnFHSSUwKQu2rus9ZhQzxvgZWlLOK1ywDT-f_6-zQKuU3gmhJSXlJVoUZcUEZ3yJXh_gpVdJA4Mmj90EwUDuNWyNsa1qJ1C-g0YZnb_Rc1QOGu2s158hgvWw1-0Yo_YZnpwNR6dSDoO6RhdGuaRvfvYK3T9uD_UOn8bjoLt29ueSPEU7qDjJoKz8S7zt5Vv4kEJQsilI8e_AFxN_X-A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><creator>Lassman, Andrew B. ; Wen, Patrick Y. ; van den Bent, Martin ; Plotkin, Scott R. ; Walenkamp, Annemiek M. E. ; Green, Adam L. ; Li, Kai ; Walker, Christopher J. ; Chang, Hua ; Tamir, Sharon ; Henegar, Leah ; Shen, Yao ; Alvarez, Mariano J. ; Califano, Andrea ; Landesman, Yosef ; Kauffman, Michael G. ; Shacham, Sharon ; Mau-Soerensen, Morten</creator><creatorcontrib>Lassman, Andrew B. ; Wen, Patrick Y. ; van den Bent, Martin ; Plotkin, Scott R. ; Walenkamp, Annemiek M. E. ; Green, Adam L. ; Li, Kai ; Walker, Christopher J. ; Chang, Hua ; Tamir, Sharon ; Henegar, Leah ; Shen, Yao ; Alvarez, Mariano J. ; Califano, Andrea ; Landesman, Yosef ; Kauffman, Michael G. ; Shacham, Sharon ; Mau-Soerensen, Morten</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-21-2225</identifier><identifier>PMID: 34728525</identifier><language>eng</language><ispartof>Clinical cancer research, 2021-11, Vol.28 (3), p.452-460</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Lassman, Andrew B.</creatorcontrib><creatorcontrib>Wen, Patrick Y.</creatorcontrib><creatorcontrib>van den Bent, Martin</creatorcontrib><creatorcontrib>Plotkin, Scott R.</creatorcontrib><creatorcontrib>Walenkamp, Annemiek M. E.</creatorcontrib><creatorcontrib>Green, Adam L.</creatorcontrib><creatorcontrib>Li, Kai</creatorcontrib><creatorcontrib>Walker, Christopher J.</creatorcontrib><creatorcontrib>Chang, Hua</creatorcontrib><creatorcontrib>Tamir, Sharon</creatorcontrib><creatorcontrib>Henegar, Leah</creatorcontrib><creatorcontrib>Shen, Yao</creatorcontrib><creatorcontrib>Alvarez, Mariano J.</creatorcontrib><creatorcontrib>Califano, Andrea</creatorcontrib><creatorcontrib>Landesman, Yosef</creatorcontrib><creatorcontrib>Kauffman, Michael G.</creatorcontrib><creatorcontrib>Shacham, Sharon</creatorcontrib><creatorcontrib>Mau-Soerensen, Morten</creatorcontrib><title>A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma</title><title>Clinical cancer research</title><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqljNFKwzAYRoMoblMfQfhfIDNJmzVXgpTp7pR1eBuyNrGRNBlJKvbtLaIXXnv1fXAOB6FbStaUcnFHSSUwKQu2rus9ZhQzxvgZWlLOK1ywDT-f_6-zQKuU3gmhJSXlJVoUZcUEZ3yJXh_gpVdJA4Mmj90EwUDuNWyNsa1qJ1C-g0YZnb_Rc1QOGu2s158hgvWw1-0Yo_YZnpwNR6dSDoO6RhdGuaRvfvYK3T9uD_UOn8bjoLt29ueSPEU7qDjJoKz8S7zt5Vv4kEJQsilI8e_AFxN_X-A</recordid><startdate>20211102</startdate><enddate>20211102</enddate><creator>Lassman, Andrew B.</creator><creator>Wen, Patrick Y.</creator><creator>van den Bent, Martin</creator><creator>Plotkin, Scott R.</creator><creator>Walenkamp, Annemiek M. E.</creator><creator>Green, Adam L.</creator><creator>Li, Kai</creator><creator>Walker, Christopher J.</creator><creator>Chang, Hua</creator><creator>Tamir, Sharon</creator><creator>Henegar, Leah</creator><creator>Shen, Yao</creator><creator>Alvarez, Mariano J.</creator><creator>Califano, Andrea</creator><creator>Landesman, Yosef</creator><creator>Kauffman, Michael G.</creator><creator>Shacham, Sharon</creator><creator>Mau-Soerensen, Morten</creator><scope>5PM</scope></search><sort><creationdate>20211102</creationdate><title>A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma</title><author>Lassman, Andrew B. ; Wen, Patrick Y. ; van den Bent, Martin ; Plotkin, Scott R. ; Walenkamp, Annemiek M. E. ; Green, Adam L. ; Li, Kai ; Walker, Christopher J. ; Chang, Hua ; Tamir, Sharon ; Henegar, Leah ; Shen, Yao ; Alvarez, Mariano J. ; Califano, Andrea ; Landesman, Yosef ; Kauffman, Michael G. ; Shacham, Sharon ; Mau-Soerensen, Morten</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_88106303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lassman, Andrew B.</creatorcontrib><creatorcontrib>Wen, Patrick Y.</creatorcontrib><creatorcontrib>van den Bent, Martin</creatorcontrib><creatorcontrib>Plotkin, Scott R.</creatorcontrib><creatorcontrib>Walenkamp, Annemiek M. E.</creatorcontrib><creatorcontrib>Green, Adam L.</creatorcontrib><creatorcontrib>Li, Kai</creatorcontrib><creatorcontrib>Walker, Christopher J.</creatorcontrib><creatorcontrib>Chang, Hua</creatorcontrib><creatorcontrib>Tamir, Sharon</creatorcontrib><creatorcontrib>Henegar, Leah</creatorcontrib><creatorcontrib>Shen, Yao</creatorcontrib><creatorcontrib>Alvarez, Mariano J.</creatorcontrib><creatorcontrib>Califano, Andrea</creatorcontrib><creatorcontrib>Landesman, Yosef</creatorcontrib><creatorcontrib>Kauffman, Michael G.</creatorcontrib><creatorcontrib>Shacham, Sharon</creatorcontrib><creatorcontrib>Mau-Soerensen, Morten</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lassman, Andrew B.</au><au>Wen, Patrick Y.</au><au>van den Bent, Martin</au><au>Plotkin, Scott R.</au><au>Walenkamp, Annemiek M. E.</au><au>Green, Adam L.</au><au>Li, Kai</au><au>Walker, Christopher J.</au><au>Chang, Hua</au><au>Tamir, Sharon</au><au>Henegar, Leah</au><au>Shen, Yao</au><au>Alvarez, Mariano J.</au><au>Califano, Andrea</au><au>Landesman, Yosef</au><au>Kauffman, Michael G.</au><au>Shacham, Sharon</au><au>Mau-Soerensen, Morten</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma</atitle><jtitle>Clinical cancer research</jtitle><date>2021-11-02</date><risdate>2021</risdate><volume>28</volume><issue>3</issue><spage>452</spage><epage>460</epage><pages>452-460</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><pmid>34728525</pmid><doi>10.1158/1078-0432.CCR-21-2225</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1078-0432 |
| ispartof | Clinical cancer research, 2021-11, Vol.28 (3), p.452-460 |
| issn | 1078-0432 1557-3265 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8810630 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research; Alma/SFX Local Collection |
| title | A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T04%3A54%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Phase%202%20Study%20of%20the%20Efficacy%20and%20Safety%20of%20Oral%20Selinexor%20in%20Recurrent%20Glioblastoma&rft.jtitle=Clinical%20cancer%20research&rft.au=Lassman,%20Andrew%20B.&rft.date=2021-11-02&rft.volume=28&rft.issue=3&rft.spage=452&rft.epage=460&rft.pages=452-460&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-21-2225&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8810630%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34728525&rfr_iscdi=true |